AI: Opportunity for More Informed Drug Development Decisions

May 23, 2018

Conversations about artificial intelligence in drug discovery and development are shifting from theoretical questions to practical implementation and impact. Detlef Hold, Global Strategy Lead, Knowledge Cycling (Genentech), and panelist for Exploring Use of Artificial Intelligence at DIA Europe 2018, discusses AI and machine learning in the workplace.

00:0000:00

Facebook Comments: